Rex Medical and Angiotech Pharmaceuticals, Inc. Complete an Agreement for the Distribution of Hemo-Stream(TM) Chronic Dialysis Catheter

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Rex Medical, L.P., today announced that it has entered into an agreement with Angiotech Pharmaceuticals, Inc. for the development and distribution of the Hemo-Stream™ Chronic Dialysis Catheter. Financial terms of this agreement were not disclosed.

MORE ON THIS TOPIC